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Abstract 
In this investigation an efficient synthesis of 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinic 
acid derivatives was achieved by one-pot reaction of one equivalent of aromatic amines with two 
equivalents of diethyl malonate in diphenyl ether and catalyzed with triethyl amine. In case of applying the 
previous condition with aromatic amines and diethyl malonate in a ratio of 2:1, no quinolone structure was 
obtained, whereas N1,N3-bis(4-bromophenyl)malonamide, as an example, was obtained in 95% yield. 
Under the same previous condition, arylmethylene-bis-3,3’-quinoline-2-ones were in one pot synthesized 
via the reaction of equal equivalents of aromatic amines and diethyl malonate together with half equivalent 
of the corresponding aromatic aldehydes. The structure of the obtained compounds was proved by IR, 
NMR and mass spectra and X-ray structure analyses.  
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Introduction 
2-Quinolones (Chen et al., 2001) have showed considerable interest because of their pharmacological 
importance (Abass et al., 2015) and various biological activities (Abass et al., 2005). Various quinolones 
are described to have antimicrobial (Eswaran et al. 2010), antifungal ((Musiol et al., 2006), enzyme 
inhibitory (Slater et al., 1992) and cytotoxic activities (Ma et al., 2004). The quinolones are also occurred 
in natural products (Junichiro et al. 2012) mainly in alkaloids (Michael et al. 2005). As for example, 
quinine is a quinoline based alkaloid structure isolated from the bark of cinchona tree (Igarashi J & 
Kobayashi Y 2005).) and is used for the treatment of malaria. Luotonin (Cagir et al., 2003) is a cytotoxic 
alkaloid as a Chinese traditional drug, which uses in treatment of rheumatism and inflammation. 
Quinarcine (Thi et al., 2008) drug is of an acridine-based alkaloid structure which has been used as an 
antimalarial agent. Kynurenic acid (Turski et al., 1988) is of quinolone structure that can be used for the 
normal metabolism of amino acids and reveals neuro active activity. Interestingly, antimalarial drugs 
consist of amino quinoline skeletons (primaquine) and used for the treatment of malaria (Turski et al., 
1988). 
Synthesis of bis-quinolones have recently much attention due to prospective high biological and 
pharmaceutical activities. For example, functionalized 4,4'-bisquinolones were synthesized by 
microwave-assisted Pd(0)-catalyzed one-pot borylation/Suzuki cross-coupling reactions or via Ni(0)-
mediated homocouplings of 4-chloroquinolin-2(1H)-one precursors (Hashim et al., 2006). Bis-conjugates 
of quinine with quinolone antibiotics and amino acid linkers which were retain in vitro antimalarial 
activity with IC50 values ranging from 12 to 207 M, similar to quinine itself (Panda et al., 2012). 
Recently we have synthesized spiro(indoline-3,4′-pyrano[3,2-c]quinoline)-3′-carbonitriles from reaction 
of quinoline-2,4-diones with 2-(2-oxo-1,2-dihydroindol-3-ylidene)malononitrile (Aly et al., 2018).  We 
also reacted quinolinediones and diethyl acetylene-dicarboxylate to give pyranoquinoline-4-carboxylates 
and (quinolin-3-yl)fumarates in good yields (El-Sheref et al., 2018). Considering the importance of the 
interesting chemical behavior of quinolones, and in view of the promising aspects and making a further 
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stepforward we report herein on the application of the one-pot technique in synthesis of the title 
compounds. 
 
2. Results and Discussion 
 
To our delight, mixing of one molar proportion of aromatic amines 1a-d to two molars of diethyl malonate 
(2) in diphenyl ether catalyzed with few drops of triethyl amine (Et3N) and when the mixture was heated at 
180 oC for 4 h, the reaction gave 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinic.bis(triethyl 
amine) derivatives 3a-d in 79-84% yields (Scheme 1). The structures of the products were fully consistent 
with their 1H NMR, 13C NMR, IR and mass spectra, elemental analyses and X-ray structure analysis as 
well. We choose compound 3a, as an example, to confirm the structures. According to elemental analysis 
spectrometry, the compound 3a would be in accordance to the molecular weight equals 638.75. In mass 
spectrum of 3a, the molecular peak is the base peak and corresponding to the molecular weight of m/z 436. 
One can then conclude the presence of the two molecules of Et3N in its crystal lattice, which was not 
noticed in mass spectrum. The latter was confirmed by the NMR spectra of 3a. The IR spectrum revealed 
bands at 3400, 3210, 1720 and 1680, corresponding to OH, NH, carbonyl-acid and 2-carbonyl-
quinolone groups. Figure 1 illustrated the NMR spectroscopic data of compound 3a, where the 1H NMR 
spectrum indicated three singlets, each for two protons at  (COOH20 (and 11.80 (NH). 
A quartet resonated at 3.17 for twelve protons of 6CH2-2Et3N and a triplet for eighteen protons of 
6CH3-2Et3N at 1.30 (see the experimental). The two adjacent methine protons were resonated in the 1H 
NMR spectrum as a doublet (J = 5.1 Hz) at 3.72 indicated that these two protons are in its trans-form 
(Figure 1). The 13C NMR spectrum confirmed the 1H NMR spectral data by showing the carbonyl-acid 
and carbonyl-quinolone carbon signals at .8 and 160.1, respectively. The CH2- and CH3-Et3N 
appeared at 50.0 and 13.7, whereas the ethano-carbons of succinic acid appeared at 38.2. In case of 
3d, the 1H NMR spectral data revealed the presence of two molecules of Et3N in its crystal lattice structure 
as a quartet at 3.20 for eighteen protons and a triplet at 1.15 for twelve protons. Another two ethyl 
protons of N-1 for quinolone moiety appeared in the 1H NMR spectrum as a quartet and triplet at 3.15 
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and 1.17, respectively (Experimental Section). The 1H NMR spectrum showed also the two methine 
protons as a doublet at 3.70 (J = 4.6 Hz). The structure of 3d was then totally proved by X-ray structure 
analysis (Figure 2).  
 
 
Scheme 1. One-pot synthesis of 2,3-bis-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinates 3a-d, 
N1,N3-bis(4-bromophenyl)malonamide (4) and arylmethylene-bis-3,3’-quinoline-2-ones 6a-e 
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Figure 1. NMR spectroscopic data some distinctive hydrogen protons and carbons of compound 3a 
 
 
Figure 2. X-ray structure analysis of compound 3d (displacement parameters are drawn at 50% 
probability level) 
 
The structure of compounds 3a-d suffers from the presence of two chiral centers. Therefore, four 
entantiomeric products should be obtained. One of these enantiomeric products is the anti-form. 
Fortunately, the reaction proceeded to give only one enantiomer. Two types of hydrogen bonds were 
formed; one was held between the oxygen of the carboxylic-OH and the hydrogen atom of the hydroxyl 
group of 4-hydroxyquinolone. The other hydrogen bond was held between the nitrogen lone pair in triethyl 
amine and the hydrogen atom of the free carboxylic-OH. Formation of such two types of hydrogen bonds 
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would be expected to stabilize the anti-form structure of 3a-d as shown in Scheme 1. The X-ray structure 
analysis indicated the presence of the two methine protons of succinic acid in its trans-form. The anti-
form of compounds 3a-d can be identified as the meso-form of absolute configuration (R,S). 
It is well-known that both ester enolates and carboxylic acid dianions can be used for oxidative 
homocoupling. The reaction mechanism can be explained as due to condensation between 1 and 2, which 
would form 2-quinolone 8. Subsequently condensation between 8 and another molecule of 2 would give 
the fused -pyranone 9 (Scheme 2). Thermolysis under basic condition of 9 would then give intermediate 
10, which was in equilibrium with entatiomeric form (Scheme 2). Finally, autoxidation of the -ketonic 
acid 10 accompanied with elimination of CO2 and rearrangement would then give salt 11. Further 
oxidation of two molecules of 11 would produce target molecule 3 (Scheme 2). To ensure the reaction 
pathway, we also heat compound 9 in diphenyl ether at 180 oC for 3 h and we successfully obtain 3.  
 
Scheme 2. Proposed mechanism describes the formation of 3 
 
We should also mention that molar ratios of both compounds 1 and 2, effect on the formed product. 
Interestingly, when we carried out the reaction between 1 and 2 in a molar ration of 2:1, we could not 
separate any quinolonoyl structure and we obtained malonamide 4 (Vennerstrom et al., 1987) (Scheme 1). 
X-ray structure analysis of 4 is as shown in Figure 3. 
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Figure 3. X-ray structure analysis of compound 4 
 
Inspired by the above results, we extended our studies to react aromatic amines 1a-d with diethyl malonate 
(2b) and aromatic aldehydes 5a-c in a molar ratio of 2:2:1 and under the condition mentioned above 
(Scheme 1). We, surprisingly obtained arylmethylene-bis-3,3’-quinoline-2-ones 6a-e in good yields as 
shown in Scheme 1. Previously, it was prepared another derivative of 6 (Bhat & Trivedi et al., 2014) by 
reacting 4-hydroxy-N-methylquinolin-2(1H)-ones with benzaldehyde derivatives under solvent- and 
catalyst-free reaction conditions at 80 oC. The reactants underwent a cascade Knoevenagel–Michael 
reaction to yield other derivatives 6 in good yields (Bhat & Trivedi et al., 2014). The main difference 
between our method and the previous method that we prepared compounds 6 in one step in relatively good 
yields. Moreover, no literatures have discussed the regio accurate structure of 6 (Madhu et al., 2017), 
weather it is in anti- or syn form.  Besides and to the best of our knowledge, there has not reported NMR 
spectral data of 6a-e derivatives. 
NMR spectral data of the product 6b (Figure 4), as an example, which was obtained from the reaction of 
4-methylaniline (1b), diethyl malonate (1b) and p-tolualdehyde (5b) were illustrated in Table 1. In 6b; the 
two quinolinone rings are spectroscopically non-equivalent, although some of their signals co-resonate; 
the simplest explanation is that their rotation is hindered so that the compound does not possess a  plane. 
The 6H methyl singlet at  2.38 must be H-6a; its attached carbon appears at  20.64. H-6a gives HMBC 
correlation with carbon signals at  131.91 and 122.03; these are assigned as C-7 and C-5 in that order, 
because the downfield of the two gives HSQC correlation with a 2H doublet at  7.42 and the upfield 
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signal correlates with the nonequivalent 1H singlets at  7.79 and 7.69. C-7 also gives HMBC correlation 
with a 2H doublet at  7.33, assigned as H-8; its attached carbon appears at  115.34 grounds as C-
2,2’,4,4’.  
 
Figure 4. Distinctive carbons of compound 6b 
The p-tolyl group is solved similarly: the 3H methyl singlet at  2.26 must be H-6f, and gives HSQC 
correlation to a carbon at  20.02. C-3f gives HMBC correlation to a 2H doublet at  7.05, assigned as H-
3d; its attached carbon appears at  128.14. H-3d gives COSY correlation with the remaining 2H doublet 
at  6.96; its attached carbon appears at  125.66. H-3c, H-3d, and C-3c also give HMBC correlation with 
the 1H singlet at  6.10, assigned as H-3a; its attached carbon appears at  34.43. The four lines between  
166-160 give HMBC correlation with H-3a, and are assigned on chemical-shift. The remaining seven 13C 
lines are assigned on chemical-shift grounds as C-3b,4a,6; C-8a; C-3e; and C-3,3’ as shown in the Table 1. 
The upfield shifts of C-3,3’ are presumably due to their positions in push-pull systems. Finally X-ray 
structure analysis of compound 6e proved its anti-form (Figure 5).    
Table 1. NMR spectral data of compound 6b 
1H NMR                                   1H-1HCOSY                                                     Assignment 
 13.18 (s; 1H), 12.73 (s; 1H)                                                                                           OH 
12.21 (s; 1H), 12.10 (s; 1H)                                                                                NH 
7.79 (s; 1H), 7.69 (s; 1H)                        7.42,7.33,2.38                                                       H-5,5’ 
7.42 (d, J = 8.0; 2H)                                    7.79,7.69,7.33,2.38                                               H-7 
7.33 (d, J = 8.4; 2H)                                    7.79, 7.69, 7.42                                                     H-8 
7.05 (d, J = 7.2; 2H)                                    6.96, 6.10, 2.26                                                     H-3d 
6.96 (d, J = 7.6; 2H)                                    7.05, 6.10                                                              H-3c 
6.10 (s; 1H)                                     7.05, 6.96, 2.26                                                     H-3a 
2.38 (s; 6H)                                     7.79, 7.69, 7.42                                                     H-6a 
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Figure 5. X-ray structure analysis of compound 6e (minor disordered parts omitted for clarity, 
displacement parameters are drawn at 50% probability level) 
 
The mechanism can be explained as due to formation of 2-quinolone 8 by the same previous steps 
mentioned in Scheme 2. Compound 8 would then condense with aldehyde 5 to give intermediate 12 
(Scheme 3). Elimination of water molecule from 12 would enable the formation of 13. Addition of 
another one molecule of 8 to 13 would, ultimately give 6 (Scheme 3).  
2.26 (s; 3H)                                     7.05, 6.10                   H-3f 
 
13C NMR                                        HSQC                         HMBC                                      Assignment 
 165.87, 164.17                                                           6.10                                               C-2,2’ 
161.64, 160.69                               6.10                                                                                      C-4,4’ 
134.56, 134.14, 134.05                  7.42,7.05, 6.96, 6.10, 2.26                                                   C-3b,4a,6 
131.91                                            7.42                               7.33, 2.38                                       C-7 
131.24                                                                                             C-8a 
128.14  7.05                    7.05, 2.26                                                                             C-3d 
125.66  6.96                    6.96, 6.10                                                                             C-3c 
122.03  7.79, 7.69               7.42, 2.38                                                                             C-5 
115.99                                                                                             C-3e 
115.34                                 7.33                    7.33                                         C-8 
110.85, 109.22                                6.96                                                                                      C-3,3’ 
34.43                                 6.10                    6.96                                         C-3a 
20.64                                 2.38                    7.42                                                  C-6a 
20.02                                 2.26                    7.05                                                  C-3f 
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Scheme 3. Suggested mechanism describes the formation of 6 
Experimental  
Melting points were determined using open glass capillaries on a Gallenkamp melting point apparatus 
(Weiss-Gallenkamp, Loughborough, UK), and are uncorrected. The IR spectra were recorded from 
potassium bromide disks with a FT device, Minia University NMR spectra were measured in DMSO-d6 on 
a Bruker AV-400 spectrometer (400 MHz for 1H, 100 MHz for 13C, and 40.55 MHz for 15N); chemical 
shifts are expressed in  (ppm), versus internal tetramethylsilane (TMS) = 0 for 1H and 13C, and external 
liquid ammonia = 0 for 15N. Coupling constants are stated in Hz. Correlations were established using 1H-1H 
COSY, and 1H-13C and 1H-15N HSQC and HMBC experiments. Mass spectra were recorded on a Finnigan 
Fab 70 eV, Institute of Organic Chemistry, Karlsruhe University, Karlsruhe, Germany. TLC was performed 
on analytical Merck 9385 silica aluminum sheets (Kieselgel 60) with Pf254 indicator; TLC's were viewed at 
max = 254 nm. Elemental analyses were carried out at the Microanalytical Center, Cairo University, Egypt. 
General procedure describes the formation of compounds 3a-d 
 
A mixture of aromatic amines 1a-d (1 mmol) and 2 (2 mmol) in 50 mL of diphenyl ether and 0.5 mL of 
Et3N was fused at 180 
oC for 4 h. The resulting white precipitate was left to cool and then poured in ice 
cold saturated solution of NaHCO3. The formed precipitate was kept standing up at room temperature for 4 
h. The precipitate which was collected by filtration was washed with 200 mL of EtOH and then dried well. 
The formed product was then recrystallized from stated solvents. 
(R,S)-2,3-Bis(4-hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl)succinate.bis-triethyl amine (3a).  
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Yellow crystals (DMF), 0.35 g (80%), m.p. 340-2 oC (decomp).  
IR (KBr): ῡ = 3400 (OH), 3210 (NH), 3030-3000 (Ar-CH), 2980-2670 (Aliph-CH), 1720, 1680 cm-1 (CO); 
1H NMR (400 MHz, DMSO-d6): 10 (s, 2H, 2COOH), 13.20 (s, 2H, 2OH), 11.80 (s, 2H, 2NH), 8.08 
(dd, 2H, J = 1.0, 0.8 Hz), 7.60-7.56 (m, 2H), 7.40-7.33 (m, 4H), 3.72 (d, 2H, J = 5.1 Hz), 3.17 (q, 12H, 
6CH2-NEt3), 1.30 ppm (t, 18H, 6CH3-2NEt3); 
13C NMR (100 MHz, DMSO-d6): .8 (2CO-
acid)160.1 (2CO-quinolone), 158.0 (Ar-2C-OH), 146.7 (Ar-2C), 133.6, 122.9, 122.8, 116.8 (Ar-2H), 
111.7,  105.4 (Ar-2C), 50.0 (6CH2-NEt3), 38.2 (Aliph-2CH), 13.7 ppm (6CH3-NEt3). 
MS (70 eV, %): m/z = 436 (M-2Et3N, 100), 306 (30), 282 (52), 153 (92), 136 (65), 106 (25).  
Anal for C34H46N4O8 (638.75): Calcd. 63.93; H, 7.26; N, 8.77. Found: C, 64.00; H, 7.30; N, 8.80. 
 
(R,S)-Diethyl 2,3-bis(4-hydroxy-6-methyl-2-oxo-1,2-dihydro-quinolin-3-yl)-succinate (3b).  
Yellow crystals (DMF/EtOH), 0.39 g (84%), m.p. 350-2 oC.  
IR (KBr): ῡ =   3460 (OH), 3230 (NH), 3060-3030 (Ar-CH), 2970-2890 (Aliph-CH), 1718, 1682 cm-1 (CO). 
1H NMR (400 MHz, DMSO-d6): 20 (s, 2COO13.20 (s, 2H, 2OH), 11.20 (s, 2H, 2NH), 8.15 (d, 
2H, J = 0.7 Hz), 7.77-7.74 (m, 2H), 6.80 (dd, 2H, J = 1.1 Hz), 3.75 (bs, 2H), 3.20 (q, 12H, 6CH2), 2.20 (s, 
6H, 2CH3), 1.20 ppm (t, 18H, CH3). 
13C NMR (100 MHz, DMSO-d6): .6 (2CO-ester)162.3 (2CO-quinolone), 158.4 (Ar-2C-OH), 
147.2, 137.2, 133.3 (Ar-2C), 126.8, 123.4 (Ar-2H), 112.4, 106.0 (Ar-2C), 50.0 (6CH2-Et3N), 37.4 (Aliph-
2CH), 21.0 (2CH3) 14.4 ppm (2CH3-ester). 
MS (70 eV, %): m/z = 465 (M-2Et3N
+, 100), 442 (18).  
Anal for C36H50N4O8 (660.80): Calcd. 64.84; H, 7.56; N, 8.40. Found: C, 64.80; H, 7.60; N, 8.76. 
(R,S)-Diethyl 2,3-bis(6-chloro-4-hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl)succinate (3c).  
 
Yellow crystals (DMF/EtOH), 0.40 g (79%), m.p. 310-2 oC.  
IR (KBr): ῡ =  3400 (OH), 3220 (NH), 3060-3030 (Ar-CH), 2970-2890 (Aliph-CH), 1715, 1672 cm-1 (CO). 
1H NMR (400 MHz, DMSO-d6): 20 (s, CO13.20 (s, 2H, 2OH), 11.80 (s, 2H, 2NH), 7.80 
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(d, 2H, J = 0.7 Hz), 7.40 (dd, 2H, J = 1.2, 0.8 Hz), 7.15 (dd, 2H, J = 1.1, 0.7 Hz, Ar-H), 3.80 (d, 2H, J = 
5 Hz), 3.20 (q, 12H, CH2-Et3N), 1.20 ppm (t, 18H, CH3-NEt3). 
13C NMR (100 MHz, DMSO-d6): .2 (2CO-acid)162.0 (2CO-quinolone), 157.6 (Ar-2C-OH), 141.6, 
135.6, 133.2 (Ar-2C), 128.6, 127.4 (Ar-2H), 113.4, 101.4 (Ar-2C), 50.0 (6CH2-NEt3), 38.0 (Aliph-2CH), 
13.0 ppm (6CH3-ester). 
MS (70 eV, %): m/z = 505 (M+, 15), 153 (37), 135 (25), 101 (100).  
Anal for C34H44Cl2N4O8 (707.64): Calcd. 57.71; H, 6.27; N, 7.92. Found: C, 57.80; H, 6.30; N, 8.00. 
 
(R,S)-2,3-Bis(1-ethyl-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)succinate.bis-triethyl-ammonium 
(3d).  
Yellow crystals (AcOEt), 0.41 g (82%), m.p. > 350 oC.  
IR (KBr): ῡ =  3450-3360 (OH), 3220 (NH), 3060-3020 (Ar-CH), 2960-2810 (Aliph-CH), 1716, 1665 cm-1 
(CO). 
1H NMR (400 MHz, DMSO-d6): (s, COOH30 (s, 7.40-7.35 (m, 4H), 7.25-
7.22 (m, 4H), 3.70 (d, 2H, J = 4.6 Hz), 3.20 (q, 12H, 6CH2-NEt3), 3.15 (q, 4H, 2CH2-NEt3), 1.17 (t, 6H, 
2CH3-Et3N), 1.15 ppm (t, 18H, 6CH3-Et3N). 
13C NMR (100 MHz, DMSO-d6): couldn’t be resolved due to bad solubility. 
MS (70 eV, %): m/z = 492 (M+, 35), 472 (40), 306 (42), 153 (100), 136 (72).  
Anal for C38H54N4O8 (694.86): Calcd. 65.68; H, 7.83; N, 8.06. Found: C, 65.80; H, 7.70; N, 8.15. 
Preparation of compound 4 
On repeating the previous procedure, a mixture of aromatic amine 1e (340 mg, 2 mmol) and 2b (160 mg, 1 
mmol) in 15 mL of diphenyl ether and 0.5 mL of Et3N was fused at 180 
oC for 4 h. The resulting pale-
yellow precipitate was left to cool.  The formed product was then recrystallized. 
 
N1,N3-Bis(4-bromophenyl)malonamide (4).  Pale yellow crystals (MeOH), 0.40 g (95%), m.p. 330-2 oC 
(lit (Vennerstrom, J L et al., 1987), 332 oC). 
IR (KBr): ῡ = 3230 (NH), 3090-3030 (Ar-CH), 2970-2820 (Aliph-CH), 1685 cm-1 (CO). 
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MS (70 eV, %): m/z = 414 (M+2, 18), 412 (M+, 30), 239 (40), 172 (100).   
General procedure describes the formation of compounds 6a-e 
On repeating the procedure, a mixture of aromatic amines 1a-d (2 mmol), 2b (320 mg, 2 mmol) and 
aromatic aldehydes 5a-c (1 mmol) in 70 mL of diphenyl ether and 0.5 mL of Et3N was fused at 180 
oC for 
4h. The resulting white precipitate was left to cool and then poured in ice cold saturated solution of 
NaHCO3. The formed precipitate was kept standing up at room temperature for 24 h. The precipitate which 
was collected by filtration was washed with about 200 mL of H2O. The formed product was then washed 
again with 200 mL of EtOH and dried well. The formed product was then recrystallized from stated 
solvents. 
 
3,3'-(Phenylmethylene)bis(4-hydroxyquinolin-2(1H)-one (6a). 
 
Yellow crystals (DMF/EtOH), 0.360 g (88 %), m.p. 335-7 oC.  
IR (KBr): ῡ = 3390 (OH), 3230 (NH), 3070 (Ar-CH), 2970 (Aliph-CH), 1650 (CO), 1605, 1580 cm-1 
(C=C); 1H NMR (400 MHz, DMSO-d6 ): 13.17 (s; 1H, OH), 12.70 (s, 1H, OH), 12.22 (s, 1H, NH), 
12.11 (s, 1H, NH), 7.80 (d 2H, H-5,5’), 7.67 (m 2H, H-6,6’), 7.44 (m 2H, H-7,7’), 7.30 (d 2H, H-8,8’), 
7.05-6.96 (m 5H, Ph-H), 6.11 ppm (s; 1H, H-3a). 
13C NMR (100 MHz, DMSO-d6): .71, 164.11 (C-2,2’), 161.33, 160.77 (C-4,4’), 135.60 (C-3b), 
134.11 (C-4a), 131.22 (C-7), 130.89 (C-8a), 122.89, 122.86, 116.78 (Ph-CH), 115.11 (C-3,3’), 34.32 ppm 
(C-3a). 
MS (70 eV, %): m/z = 410 (M+, 34), 333 (100), 161 (55), 77 (66).  
Anal for C25H18N2O4 (410.42): Calcd. C, 73.16; H, 4.42; N, 6.83. Found: C, 73.22; H, 4.36; N, 6.95. 
  
3,3'-(p-Tolylmethylene)bis(4-hydroxy-6-methyl-quinolin-2(1H)-one (6b). 
 
Yellow crystals (DMF/EtOH), 0.365 g (80 %), m.p. 358-60 oC.  
IR (KBr): ῡ = 3410 (OH), 3222 (NH), 3045-3020 (Ar-CH), 2989 (Aliph-CH), 1646 (CO), 1610, 1590 cm-1 
(C=C). 
NMR (400 MHz, DMSO-d6) (Table 1). 
MS (70 eV, %): m/z = 452 (M+, 38), 361 (100), 187 (24), 91 (66).  
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Anal for C28H24N2O4 (452.50): Calcd. C, 74.32; H, 5.35; N, 6.19. Found: C, 74.22; H, 5.43; N, 6.35. 
3,3'-(p-Tolylmethylene)bis(4-hydroxy-quinolin-2(1H)-one (6c). 
 
Yellow crystals (DMF/EtOH), 0.360 g (88%), m.p. > 360 oC.  
IR (KBr): ῡ = 3405 (OH), 3225 (NH), 3091 (Ar-CH), 2956 (Aliph-CH), 1648 (CO), 1600, 1590 cm-1 
(C=C). 1H NMR (400 MHz, DMSO-d6): 13.11 (s 1H, OH), 12.78 (s 1H, OH), 12.20 (s 1H, NH), 11.99 
(s 1H, NH), 7.81, 7.76 (m, 2H, H-5,5’), 7.42 (m 2H, H-7), 7.03 (d J = 7.1 Hz, 2H, H-3d), 6.98 (m 2H, H-
3c), 6.12 (s, 1H, H-3a),  2.23 ppm (s, 3H, H-3f). 
13C NMR (100 MHz, DMSO-d6): .80, 164.21 (C-2,2’), 161.63, 159.97 (C-4,4’), 135.55 (C-3b), 
134.18 (C-4a), 132.01 (C-8a), 128.66 (C-6), 128.21 (C-3d), 125.08 (C-3c), 123.11 (C-5), 115.78 (C-3e), 
115.55 (C-8), 110.99 (C-3,3’), 34.33 (C-3a), 20.10  ppm (C-3f). 
MS (70 eV, %): m/z = 424 (M+, 40), 333 (100), 161 (67), 77 (77).  
Anal for C26H20N2O4 (424.45): Calcd. C, 73.57; H, 4.75; N, 6.60. Found: C, 73.65; H, 4.71; N, 6.51. 
3,3'-((4-chlorophenyl)methylene)bis(4-hydroxy-6-methylquinolin-2(1H)-one) (6d). 
 
Yellow crystals (DMF/EtOH), 0.32 g (68%), m.p. 280-2 oC.  
IR (KBr): ῡ = 3385 (OH), 3210 (NH), 3077 (Ar-CH), 2980 (Aliph-CH), 1646 (CO), 1605, 1588 cm-1 
(C=C). 1H NMR (400 MHz, DMSO-d6 ): 13.21 (s, 1H, OH), 12.70 (s; 1H, OH), 12.21 (s, 1H, NH), 
12.08 (s, 1H, NH), 7.77 (s, 2H, H-5,5’), 7.40 (d, J = 7.80 Hz, 2H, H-7), 7.03 (d, J = 7.0 Hz, 2H, H-3d), 6.97 
(d, J = 7.2 Hz, 2H, H-3c), 6.10 (s, 1H, H-3a), 2.33 ppm (s, 6H, H-6a). 
13C NMR (100 MHz, DMSO-d6): .67, 164.20 (C-2,2’), 161.66, 160.13 (C-4,4’), 135.54 (C-3b), 
134.18 (C-4a), 134.09 (C-6), 131.87 (C-7), 131.11 (C-8a), 130.32 (C-3e), 128.22 (C-3d), 125.18 (C-3c), 
122.32 (C-5), 115.48 (C-8), 110.90, 109.66 (C-3,3’), 34.30 (C-3a), 20.55 ppm (C-6a). 
MS (70 eV, %): m/z = 472 (M+, 71), 361 (100), 187 (67), 111 (43), 77 (65).  
Anal for C27H21ClN2O4 (472.92): Calcd. C, 68.57; H, 4.48; Cl, 7.50; N, 5.92. Found: C, 68.65; H, 4.55; N, 
6.11. 
3,3'-(p-Tolylmethylene)bis(1-ethyl-4-hydroxy-quinolin-2(1H)-one (6e). 
Yellow crystals (DMF/EtOH), 0.400 g (83%), m.p. 312-4 oC.  
 15 
 
IR (KBr): ῡ = 3390 (OH), 3220 (NH), 3052 (Ar-CH), 2988 (Aliph-CH), 1649 (CO), 1600, 1580 cm-1 (Ar-
C=C).  
MS (70 eV, %): m/z = 480 (M+, 71), 389 (100), 189 (32), 91 (43), 77 (50).  
Anal for C30H28N2O4 (480.55): Calcd. C, 74.98; H, 5.87; N, 5.83. Found: C, 75.15; H, 5.75; N, 6.01. 
Supporting Information:  
 
Crystal Structure Determinations 
 
The single-crystal X-ray diffraction studies were carried out on a Bruker D8 Venture diffractometer with 
Photon100 detector at 123(2) K using Cu-K radiation (3d, 6e,  = 1.54178 Å) or Mo-K radiation (4,  = 
0.71073 Å). Direct Methods (3d, 6e, SHELXS-97) (Sheldrick et al., 2008) or dual space methods (4, 
SHELXT for 5a) (Sheldrick et al. 2015) were used for structure solution and refinement was carried out 
using SHELXL-2014 (full-matrix least-squares on F2) (Sheldrick et al., 2015). Hydrogen atoms were 
localized by difference electron density determination and refined using a riding model (H(O, N) free). 
Semi-empirical absorption corrections were applied. For 4 and 6e an extinction of corrections was applied. 
In 6e one NEt-group is disordered. The absolute structure of 4 was determined by refinement of Parsons’ x-
parameter (Parson et al., 2013). 
3d: colourless crystals, C26H22N2O8
2- ∙ 2(C6H16N)+, Mr = 694.85, crystal size 0.18 × 0.14 × 0.12 mm, 
monoclinic, space group P21/c (No. 14), a = 9.9912(3) Å, b = 10.7399(3) Å, c = 16.4621(4) Å, β = 
94.647(1)°, V = 1760.65(8) Å3, Z = 2, ρ = 1.311 Mg/m-3, µ(Cu-Kα) = 0.747 mm-1, F(000) = 748, 2max = 
144.2°, 17106 reflections, of which 3467 were independent (Rint = 0.025), 232 parameters, 2 restraints, R1 = 
0.039 (for 3201 I > 2σ(I)), wR2 = 0.106 (all data), S = 1.03, largest diff. peak / hole = 0.303 / -0.237 e Å-3. 
 
4: colourless crystals, C15H12Br2N2O2, Mr = 412.02, crystal size 0.28 × 0.14 × 0.05 mm, orthorhombic, 
space group Pca21 (No. 29), a = 9.5819(4) Å, b = 18.4026(7) Å, c = 16.9824(7) Å, V = 2994.5(2) Å
3, Z = 8, 
ρ = 1.828 Mg/m-3, µ(Mo-Kα) = 5.419 mm-1, F(000) = 1616, 2max = 55.4°, 104279 reflections, of which 
6908 were independent (Rint = 0.048), 392 parameters, 5 restraints, R1 = 0.028 (for 6424 I > 2σ(I)), wR2 = 
0.063 (all data), S = 1.08, largest diff. peak / hole = 0.754 / -0.420 e Å-3, x = 0.000(6). 
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6e: colourless crystals, C30H28N2O4 ∙ C3H7NO, Mr = 553.64, crystal size 0.38 × 0.30 × 0.24 mm, 
monoclinic, space group P21/c (No. 14), a = 11.4000(5) Å, b = 11.1444(5) Å, c = 22.8990(9) Å, β = 
103.551(2)°, V = 2828.2(2) Å3, Z = 4, ρ = 1.300 Mg/m-3, µ(Cu-Kα) = 0.711 mm-1, F(000) = 1176, 2max = 
144.0°, 25228 reflections, of which 5552 were independent (Rint = 0.023), 379 parameters, 8 restraints, R1 = 
0.037 (for 5095 I > 2σ(I)), wR2 = 0.101 (all data), S = 1.05, largest diff. peak / hole = 0.270 / -0.245 e Å-3. 
CCDC 1824942 (3d), 1827436 (4), and 1824943 (6e) contain the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
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